AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.600
+0.070 (2.77%)
Apr 24, 2025, 4:00 PM EDT - Market closed
AbCellera Biologics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$7.50
Upside
+188.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +92.31% | Apr 16, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +284.62% | Feb 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +53.85% | Jan 8, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $14 → $12 | Strong Buy | Reiterates | $14 → $12 | +361.54% | Nov 5, 2024 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 20, 2024 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +92.31% | Jul 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +169.23% | May 8, 2024 |
| Benchmark | Benchmark | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 22, 2024 |
| Stifel | Stifel | Strong Buy Maintains $21 → $17 | Strong Buy | Maintains | $21 → $17 | +553.85% | Feb 21, 2024 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +130.77% | Dec 5, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +669.23% | Oct 13, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +361.54% | Aug 31, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $24 | Strong Buy | Maintains | $27 → $24 | +823.08% | Aug 4, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $34 → $28 | Buy | Maintains | $34 → $28 | +976.92% | May 5, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.